Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical syndrome associated
with poor quality of life, substantial health-care resource utilization, and premature mortality …

Heart failure with preserved ejection fraction (HFPEF) is increasingly recognized as a major
public health problem worldwide. Significant advances have been made in our …

Heart failure (HF) is a complex syndrome that affects approximately 6.5 million adults in the
United States. About half of the 6.5 million adults with HF are estimated to be individuals with …

The prevalence of heart failure (HF) and its subtype, HF with preserved ejection fraction
(HFpEF), is on the rise due to aging of the population. HFpEF is convergence of several …

Understanding how patients with heart failure with preserved ejection fraction (HFPEF) die
provides insight into the natural history and pathophysiology of this complex syndrome …

Background—The contributions of risk factors and disease pathogenesis to heart failure with
preserved ejection fraction (HFPEF) versus heart failure with reduced ejection fraction …

Aims Whether prevalence and mortality of patients with heart failure with preserved or mid-
range (40–49%) ejection fraction (HFpEF and HFmREF) are similar to those of heart failure …

Aims Heart failure (HF) with normal or preserved left ventricular (LV) ejection fraction
(HFPEF) has been reported to be associated with similar outcome as HF with reduced EF …

Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with
preserved ejection fraction (HFpEF) has traditionally received less attention than its main …

Heart failure with preserved ejection fraction (HFpEF), which currently represents
approximately 50% of heart failure (HF) cases, is common and associated with high …